Stock APVO APTEVO THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Aptevo Therapeutics Inc.

Equities

APVO

US03835L3069

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
0.7061 USD +3.84% Intraday chart for Aptevo Therapeutics Inc. 0.00% -91.13%
04-11 US Equity Markets Close Mixed After March Producer Price Inflation Data MT
04-11 Top Midday Decliners MT

Evolution of the average Target Price on Aptevo Therapeutics Inc.

Price target over the last 5 years

History of analyst recommendation changes

880f5f9f41917546bccf3e18339.-hTZymizrKxTfA-hFbiusSGm4vcko-ZeBCwDZ6vlya4.smWTphzH9PxnKzn3J8LLwnf0ur1CwKAbS0hBX5PI-vqAepb_BsXA6REpYA~ac15c18077b76c7904924004ef64b48d

Analyst Recommendations on Aptevo Therapeutics Inc.

Wall Street Set to Open Higher as Investors Await Inflation Data, Fed Rate Decision in Coming Days MT
US Futures Move Modestly Higher Monday Ahead of Inflation Data Tuesday, Fed Rate Decision Meeting Conclusion Wednesday MT
Aptevo Therapeutics Inc. Announces APVO436, in Combination with Venetoclax and Azacitidine, Achieved a 100% Clinical Benefit Rate in Venetoclax Treatment Naïve AML Patients CI
Piper Sandler Adjusts Price Target on Aptevo Therapeutics to $20 From $69, Reiterates Overweight Rating MT
Roth Capital Adjusts Aptevo Therapeutics' Price Target to $36 From $50, Reiterates Buy Rating MT
APTEVO THERAPEUTICS : Roth Capital Adjusts Aptevo Therapeutics PT to $50 From $64, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7061 USD
Average target price
671 USD
Spread / Average Target
+94,928.92%
High Price Target
880 USD
Spread / Highest target
+124,528.09%
Low Price Target
462 USD
Spread / Lowest Target
+65,329.75%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Aptevo Therapeutics Inc.

Piper Sandler
Roth Capital Partners

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. APVO Stock
  4. Consensus Aptevo Therapeutics Inc.